The mission of a pharmaceutical company is to make lives better through better medicine.
Since its foundation, for the past 75 years, Chong Kun Dang only has developed pharmaceutical products of good quality based on the dignity of human lives.
Chong Kun Dang has set up the implementation of a healthy society without diseases as the company ideology. This is a value that will never change as long as Chong Kun Dang exists as a pharmaceutical company.
In the 21st century, all sorts of fatal or serious diseases are conquered by pharmaceutical products using genetic technology and biotechnology.
The all-time human dream of long lives without diseases can come true. Based on our future-oriented management, we will constantly challenge biotechnology which is our core competence. BINT(Biotechnology, Information technology, Nanotechnology) has been recently highlighted as the main industry to lead the 21st century. We believe the pharmaceutical industry is going to be the core industry of BINT.
Chong Kun Dang has developed a new anticancer drug, Camtobel, and a new antidiabetic, Duvie based on world-class technology and manufacturing facilities.
Chong Kun Dang is also spurring the development of global new drugs in addition to targeted anticancer drugs, an antiobesity drug, and a biosimilar for the treatment of anemia.
Furthermore, we, as a Korean representative pharmaceutical company, are implementing customer-driven management to fulfill our commitment and responsibility and doing our utmost for customer satisfaction through a consumer-oriented business culture. Chong Kun Dang who has been playing a leading role in the Korean pharmaceutical industry will establish ourselves as a Korean leading pharmaceutical company and do our best to become Chong Kun Dang in the world in the 21st century.